Herberman R B
Cancer. 1976 Jan;37(1 suppl):549-61. doi: 10.1002/1097-0142(197601)37:1+<549::aid-cncr2820370720>3.0.co;2-l.
A variety of immunologic approaches can be applied to the diagnosis of human cancer, and these have the potential advantages of specificity and sensitivity. Many tumor distinctive markers have been detected in the circulation of cancer patients. Cancer patients frequently have detectably depressed immune competence, but also have cell-mediated and humoral immune reactivity against tumor-associated antigens. Radiolabeling of specific antibodies may allow localization in vivo of tumors. With each of these potential immunodiagnostic approaches, it is necessary to systematically evaluate the assays and determine their value for specific clinical applications.
多种免疫方法可应用于人类癌症的诊断,这些方法具有特异性和敏感性的潜在优势。在癌症患者的循环系统中已检测到许多肿瘤特异性标志物。癌症患者的免疫能力常常明显降低,但也具有针对肿瘤相关抗原的细胞介导免疫反应和体液免疫反应。特异性抗体的放射性标记可能有助于在体内定位肿瘤。对于每一种潜在的免疫诊断方法,都有必要系统地评估检测方法并确定其在特定临床应用中的价值。